准备为患者定制的N-of-1无意义寡核酸治疗来治疗罕见疾病
Harry Wilton-Clark1, Eric Yan2, Toshifumi Yokota1
1Department of Medical Genetics, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB T6G 2R3, Canada.
Genes
|July 27, 2024
概括
开发用于罕见疾病的反感应疗法,特别是通过N-of-1试验,由于新的FDA指南,现在更可行. 这提高了罕见遗传疾病的治疗选择.
科学领域:
- 生物医学科学 生物医学科学
- 遗传学 遗传学 是一个
- 药理学 药理学是指药理学的学科.
背景情况:
- 开发用于罕见疾病的治疗方法面临着重大的财务,监管和后勤障碍.
- 反意义疗法为治疗罕见遗传疾病提供了一种有前途的方法.
- 单个患者的N-of-1试验正在成为罕见疾病治疗开发的可行策略.
研究的目的:
- 突出N-of-1反感疗法在罕见疾病中的潜力.
- 讨论FDA新指南对开发N-of-1反感应疗法的影响.
- 为了强调罕见疾病治疗开发的进步.
主要方法:
- 审查最近的N-of-1反意义疗法发展,包括米拉研究.
- 分析FDA对N-of-1罕见疾病抗意义疗法开发的新政策.
- 检查罕见病治疗创作中的挑战和解决方案.
主要成果:
- 几种N-of-1反感疗法已成功开发用于罕见疾病.
- 美国食品和药物管理局已经为N-of-1罕见疾病的反感性治疗制定了具体的指导方针.
- 这些变化解决了罕见病药物开发中的关键局限性.
结论:
- 新的FDA指导方针为推进N-of-1反感应疗法开发提供了一个框架.
- 这一政策转变预计将加速为罕见疾病创造有效的治疗方法.
- 这种方法对罕见疾病中未得到满足的医疗需求的患者具有显著的前景.
关键词:
没有1的N-of-1这是一种反意义的寡核酸.这是一个令人惊的Atipeksen.突出跳过的突出跳过这就是米拉森.肌肉发育不良 肌肉发育不良 肌肉发育不良个性化医疗是个性化的医疗.罕见疾病是一种罕见的疾病.拼接切换 连接切换 连接切换瓦勒里亚森的情况更多相关视频
14:20Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
16.7K
07:02Evaluation of Exon Inclusion Induced by Splice Switching Antisense Oligonucleotides in SMA Patient Fibroblasts
Published on: May 11, 2018
13.4K
相关概念视频
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
siRNA - Small Interfering RNAs
16.7K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.7K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
